Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
35.06 USD | -1.04% | -2.91% | -9.29% |
May. 13 | Baxter International's Clinolipid Injection Approved for Expanded Use in US | MT |
May. 10 | TD Cowen Downgrades Baxter International to Hold From Buy, Price Target is $40 | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.29% | 18.05B | |
-6.00% | 182B | |
+1.69% | 111B | |
-3.74% | 68.48B | |
+0.30% | 49.69B | |
+7.48% | 44.46B | |
+2.33% | 40.67B | |
+22.53% | 31.22B | |
+1.33% | 26.09B | |
+15.30% | 25.32B |
- Stock Market
- Equities
- BAX Stock
- News Baxter International Inc.
- Transcript : Baxter International Inc. Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-09-2023 09